The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
2010 · Cancer Cell · 1,966 citations
https://doi.org/10.1016/j.ccr.2010.01.020
J
Jay Patel
Cameco (Canada)(CA)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
133
Papers
11.2K
Citations
31
h-index
45
i10-index
Jay Patel is an academic researcher from Cameco (Canada). The author has contributed to research in topics: Acute Myeloid Leukemia Research & Myeloproliferative Neoplasms: Diagnosis and Treatment & Chronic Myeloid Leukemia Treatments. The author has an h-index of 31, co-authored 114 publications.
ORCID: 0000-0001-6531-3225Papers by this author
worksCombining Biomarkers with EMR Data to Identify Patients in Different Phases of Sepsis
2017 · Scientific Reports · 74 citations
https://doi.org/10.1038/s41598-017-09766-1
Comprehensive response criteria for myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: a proposal from the MLN International Working Group
2023 · Leukemia · 13 citations
https://doi.org/10.1038/s41375-023-01859-3
Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms
2024 · Blood Cancer Journal · 12 citations
https://doi.org/10.1038/s41408-024-01077-9
Transplantation Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to Care
2023 · Transplantation and Cellular Therapy · 7 citations
https://doi.org/10.1016/j.jtct.2023.04.011
MPN-384 A Phase 2 Study of Pemigatinib (FIGHT-203; INCB054828) in Patients With Myeloid/Lymphoid Neoplasms With Fibroblast Growth Factor Receptor 1 (FGFR1) Gene Rearrangement
2024 · Clinical Lymphoma Myeloma & Leukemia · 2 citations
https://doi.org/10.1016/s2152-2650(24)01430-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat